Valuation West Pharmaceutical Services, Inc. Boerse Muenchen

Stocks

Market Closed - Boerse Muenchen 16:44:02 2026-09-25 EDT			5-day change	1st Jan Change
325.20 ^EUR	-1.00%		+3.25%	+40.29%

09-23	US companies face rise in cyber attacks	RE
09-22	West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	34,744	17,424	26,053	23,723	19,795	26,070	-	-
Change	-	-49.85%	49.53%	-8.95%	-16.56%	31.7%	-	-
Enterprise Value (EV) ¹	34,744	16,738	25,406	23,441	19,206	25,567	25,097	24,728
Change	-	-51.82%	51.78%	-7.74%	-18.07%	33.12%	-1.84%	-1.47%
P/E	54.1x	30.4x	44.7x	49x	40.5x	43.2x	37.6x	33.5x
PBR	14.9x	6.5x	8.98x	8.83x	5.95x	8.25x	7.28x	6.48x
PEG	-	-2.8x	23.04x	-3.2x	27.09x	1.6x	2.5x	2.8x
Capitalization / Revenue	12.3x	6.04x	8.83x	8.2x	6.44x	7.73x	7.27x	6.76x
EV / Revenue	12.3x	5.8x	8.61x	8.1x	6.25x	7.58x	7x	6.42x
EV / EBITDA	39.3x	19x	30.7x	32.2x	24.2x	27.2x	24.1x	21.3x
EV / EBIT	45.6x	22x	36.8x	40.9x	30.9x	33.7x	29.6x	26x
EV / FCF	105x	38.1x	61.3x	84.8x	41x	59.4x	44.2x	34.1x
FCF Yield	0.95%	2.63%	1.63%	1.18%	2.44%	1.68%	2.26%	2.93%
Dividend per Share ²	0.69	0.74	0.78	0.82	0.85	0.9025	0.9729	1.118
Rate of return	0.15%	0.31%	0.22%	0.25%	0.31%	0.24%	0.26%	0.3%
EPS ²	8.67	7.73	7.88	6.69	6.79	8.575	9.865	11.04
Distribution rate	7.96%	9.57%	9.9%	12.3%	12.5%	10.5%	9.86%	10.1%
Net sales ¹	2,832	2,887	2,950	2,893	3,074	3,374	3,587	3,855
EBITDA ¹	884.7	882.6	827.9	728.2	793.8	940.6	1,041	1,159
EBIT ¹	762.4	762	690.6	572.8	622.4	757.9	847.9	951.8
Net income ¹	661.8	585.9	593.4	492.7	493.7	617.4	702.6	781.8
Net Debt ¹	-	-685.4	-647.1	-282	-588.5	-503.3	-973.5	-1,342
Reference price ²	469.01	235.35	352.12	327.56	275.14	370.44	370.44	370.44
Nbr of stocks (in thousands)	74,080	74,033	73,990	72,422	71,943	70,376	-	-
Announcement Date	2/17/22	2/16/23	2/15/24	2/13/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBOTT LABORATORIES	28.7x	3.97x	15.34x	2.54%	175B
MEDTRONIC PLC	18.75x	3.44x	12.31x	3.18%	113B
CENCORA, INC.	16.81x	0.2x	12.34x	0.77%	58.57B
BECTON, DICKINSON AND COMPANY	35.42x	3.42x	11.72x	2.13%	50.07B
HOYA CORPORATION	28.64x	7.07x	18.26x	1.4%	49.92B
DEXCOM, INC.	34.72x	6.1x	19.16x	-.--%	32.69B
MEDLINE INC.	45.51x	1.29x	11.97x	0.21%	30.44B
WEST PHARMACEUTICAL SERVICES, INC.	43.2x	7.58x	27.18x	0.24%	26.07B
SARTORIUS STEDIM BIOTECH	54.38x	7.25x	23.3x	0.39%	23.55B
Average	34.01x	4.48x	16.84x	1.21%	62.22B
Weighted average by Cap.	29.06x	3.98x	15.27x	1.87%